?? ???? TRuE-AD1 and TRuE-AD2: Ruxolitinib cream significantly reduces skin pain as early as 12 hours post-application and sustains improvements in symptoms and quality of life through 52 weeks, according to the results from two studies looking at ruxolitinib in individuals with mild-to-moderate atopic dermatitis. Read the story ?? https://bit.ly/40MJj17 #dermatology #atopicdermatitis #ruxolitinib #skinhealth #skin
